Detalhe da pesquisa
1.
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.
Br J Haematol
; 172(3): 428-38, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26567765
2.
Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse.
Diagnostics (Basel)
; 10(7)2020 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32635531
3.
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial.
Cancers (Basel)
; 12(12)2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287189
4.
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome.
PLoS One
; 11(2): e0148972, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26872047